TIDES Europe
Post-Event Report
October 2023
TIDES Europe 2023 witnessed the largest turnout in the history of the event, welcoming more than 600 attendees from across the globe. The conference took place 30 October – 1 November in Amsterdam, NL and featured new data & case studies from...
Introduction
RNAi Therapeutics: Liver, CNS and Beyond
Further Development of AJIPHASE oligonucleotide manufacturing process: reducing in environmental impact
From Lab to Commercial: Oligo Development Scale-up Considerations
QC for Oligos - From HPLC Development to GMP
Revolutionizing Nucleic Acid Synthesis with Engineered Enzymes
LNP Formulation Screening, A CDMO Perspective
The Process Development for Blockmer™ Synthesis in Liquid-phase
Exclusive Exhibitor Highlights
Using Plants as Biofactories to Produce Therapeutic Peptides
LNP Production for mRNA Vaccines, Therapeutics and for Gene-editing: Proof-of-concept for a Versatile Process
Characterization and Quantification of Oligonucleotide and RNA Impurities by CE and LC-MS
New Directions in Flow-based Peptide and Protein Synthesis
Application of PAT for Process Understanding and Control Strategy during Development and Manufacturing of Oligonucleotides
Developing a Composite Purity Analysis of Single Guide RNA
One-step Oligonucleotide Purification with On-column 5’-DMT Cleavage Using a Novel Chromatography Resin
Intracellular Therapies and Oligonucleotide Applications